Key terms
About MYO
Myomo, Inc. is a wearable medical robotics company, which engages in the business of developing, designing, and producing myoelectric orthotics for people with neuromuscular disorders. The firm is also involved in selling products through various other sales channels including through orthotics and prosthetics providers, veterans’ administration, and to distributors in certain accounts and geographic markets. The company was founded by Stephen Kelly, John McBean, Mira Sahney, and Kailas N. Narendran on September 1, 2004 and is headquartered in Boston, MA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest MYO news
Mar 28
4:33pm ET
Myomo Inc Enhances Board with Expert Heather Getz
Mar 27
7:03am ET
Myomo transferred with a Buy at Alliance Global Partners
Mar 27
4:55am ET
Myomo management to meet with Maxim
Mar 20
2:13pm ET
Myomo management to meet with Maxim
Mar 09
7:36am ET
Myomo Inc.: Strong Growth and Regulatory Tailwinds Support Buy Rating
Mar 08
7:10am ET
Myomo price target raised to $6.65 from $4.60 at Alliance Global Partners
Mar 07
4:18pm ET
Myomo sees Q1 revenue $4.1M-$4.3M, consensus $4.5M
Mar 07
4:17pm ET
Myomo reports Q4 EPS (7c), consensus (6c)
Feb 22
5:13pm ET
Myomo Inc Updates Executive Financial Agreements
Jan 24
8:30am ET
Three new option listings on January 24th
Jan 17
8:10am ET
Myomo to sell 1.578M shares at $3.80 in registered direct offering
Jan 17
8:03am ET
Myomo sees Q4 revenue $4.6M-$4.8M, consensus $4.86M
No recent press releases are available for MYO
MYO Financials
Key terms
Ad Feedback
MYO Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
MYO Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
